AdvaMed Pushes State Lobbying Actions
This article was originally published in The Gray Sheet
Executive Summary
The national trade group and regional trade associations unveiled a state-based “competitiveness agenda” last week, partially in response to frustrations at the federal level.
You may also be interested in...
Not-So-Happy New Year: Device Tax Not Addressed In Fiscal Cliff Law
There’s no mention of a device tax delay or repeal in the measure signed by President Obama Jan. 2, and the new law contains some Medicare payment cuts as one-year “Doc Fix” pay-fors.
Probiotics And Cold Remedies Boost Recordati In 2023
Italy's Recordati saw its OTC sales grow by 10% in 2023 driven by the recovery of the cough & cold market and a growing demand for probiotics.
Falling Sales Force New Priorities At Roche
The Swiss major brings a new ruthlessness to the compounds in its pipeline: if they’re not first or best, they’re out.